This is a Validated Antibody Database (VAD) review about dog VEGFA, based on 29 published articles (read how Labome selects the articles), using VEGFA antibody in all methods. It is aimed to help Labome visitors find the most suited VEGFA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
VEGFA synonym: VEGF; vascular endothelial growth factor A; VEGF-A; VPF; vascular endothelial growth factor 188; vascular permeability factor

Abcam
mouse monoclonal (VG-1)
  • immunohistochemistry; rat; 1:25; loading ...; fig 4d
  • western blot; rat; 1:1000; loading ...; fig 5a
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry on rat samples at 1:25 (fig 4d) and in western blot on rat samples at 1:1000 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 5
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5). Braz J Med Biol Res (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; mouse; fig 6
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on mouse samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; rabbit; 1:1000; fig 7
Abcam VEGFA antibody (abcam, ab1316) was used in western blot on rabbit samples at 1:1000 (fig 7). Mol Med Rep (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; human; fig 5
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on human samples (fig 5). BMC Complement Altern Med (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2a
Abcam VEGFA antibody (Abcam, VG-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a). BMC Cancer (2015) ncbi
mouse monoclonal (VG-1)
  • western blot; rat; fig f4b
In order to examine the effect of advanced glycation end products on the retina, Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on rat samples (fig f4b). Mol Med Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 5
  • western blot; mouse; 1:300; fig 6
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5) and in western blot on mouse samples at 1:300 (fig 6). Sci Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; mouse; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000. Reprod Sci (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Onco Targets Ther (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; mouse; 1:500; tbl 6
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (tbl 6). PLoS ONE (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rabbit; 1:500; loading ...; fig 4
  • ELISA; rabbit; 1:500; loading ...; fig 1
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rabbit samples at 1:500 (fig 4) and in ELISA on rabbit samples at 1:500 (fig 1). Oncol Lett (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; human; 1:200; fig 4
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 4). Mol Med Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
Abcam VEGFA antibody (AbCam, VG-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). BMC Cancer (2014) ncbi
mouse monoclonal (VG-1)
  • western blot; rat; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:1000
  • western blot; rat; 1:1000
In order to investigate the mechanisms by which mesenchymal stem cells alleviate acute liver failure in rats, Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 and in western blot on rat samples at 1:1000. Genet Mol Res (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:2000
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the involvement of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma, Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Mol Sci (2014) ncbi
mouse monoclonal (VG-1)
  • blocking or activating experiments; mouse
Abcam VEGFA antibody (Abcam, ab1316) was used in blocking or activating experiments on mouse samples . J Biomed Res (2012) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncol Lett (2013) ncbi
mouse monoclonal (VG-1)
  • ELISA; rat; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in ELISA on rat samples at 1:1000. Microvasc Res (2012) ncbi
Invitrogen
mouse monoclonal (VG1)
  • immunocytochemistry; mouse; fig 3
In order to study proteins absent in the eyes during pathological and developmental angiogenesis, Invitrogen VEGFA antibody (ThermoFisher Scientific, VG1) was used in immunocytochemistry on mouse samples (fig 3). Am J Pathol (2016) ncbi
mouse monoclonal (VG1)
  • western blot; rat; 1:200
In order to investigate the benefits of replacing a PMMA spacer with a semi-flexible medical grade silicone spacer for long bone defect reconstruction, Invitrogen VEGFA antibody (Thermo, MA1-16629) was used in western blot on rat samples at 1:200. Acta Biomater (2015) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; 1:50
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen VEGFA antibody (LabVision, VG1) was used in immunohistochemistry - paraffin section on human samples at 1:50. APMIS (2015) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen VEGFA antibody (Lab Vision, VG1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate the parameters for the identification of multiple myeloma patients suitable for bortezomib therapy, Invitrogen VEGFA antibody (Zymed, VG1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Cancer Res (2009) ncbi
Santa Cruz Biotechnology
mouse monoclonal (VG-1)
  • western blot; rat; fig 7
Santa Cruz Biotechnology VEGFA antibody (santa Cruz, sc-53462) was used in western blot on rat samples (fig 7). BMC Cancer (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; human; fig 4
  • western blot; mouse; fig 8
In order to learn about inhibition of stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis via cucurbitacin B, Santa Cruz Biotechnology VEGFA antibody (Santa Cruz, S C-53462) was used in western blot on human samples (fig 4) and in western blot on mouse samples (fig 8). Sci Rep (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry; rat
Santa Cruz Biotechnology VEGFA antibody (Santa Cruz biotechnology, sc-53462) was used in immunohistochemistry on rat samples . Biochem Biophys Res Commun (2014) ncbi
Articles Reviewed
  1. Zhang H, Zhang P, Gao Y, Li C, Wang H, Chen L, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57-64 pubmed publisher
  2. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed publisher
  3. Li X, Chen Y, Wang L, Shang G, Zhang C, Zhao Z, et al. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Braz J Med Biol Res. 2016;49: pubmed publisher
  4. Chung S, Gillies M, Yam M, Wang Y, Shen W. Differential expression of microRNAs in retinal vasculopathy caused by selective Müller cell disruption. Sci Rep. 2016;6:28993 pubmed publisher
  5. Wang Y, Li Y, Song L, Li Y, Jiang S, Zhang S. The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits. Mol Med Rep. 2016;14:234-42 pubmed publisher
  6. Abu N, Akhtar M, Yeap S, Lim K, Ho W, Abdullah M, et al. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro. BMC Complement Altern Med. 2016;16:86 pubmed publisher
  7. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed publisher
  8. Wang Y, Tadjuidje E, Pandey R, Stefater J, Smith L, Lang R, et al. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis. Am J Pathol. 2016;186:568-78 pubmed publisher
  9. Pinheiro C, Garcia E, Morais Santos F, Moreira M, Almeida F, Jubé L, et al. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. BMC Cancer. 2015;15:835 pubmed publisher
  10. Kim C, Kim J, Jo K, Lee Y, Sohn E, Yoo N, et al. OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep. 2015;12:7279-84 pubmed publisher
  11. Yang S, He H, Ma Q, Zhang Y, Zhu Y, Wan X, et al. Experimental study of the protective effects of SYVN1 against diabetic retinopathy. Sci Rep. 2015;5:14036 pubmed publisher
  12. Bacallao K, Plaza Parrochia F, Cerda A, Gabler F, Romero C, Vantman D, et al. Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia. Reprod Sci. 2016;23:211-8 pubmed publisher
  13. Li C, Wang L, Zheng L, Zhan X, Xu B, Jiang J, et al. SIRT1 expression is associated with poor prognosis of lung adenocarcinoma. Onco Targets Ther. 2015;8:977-84 pubmed publisher
  14. Chan N, He S, Spee C, Ishikawa K, Hinton D. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS ONE. 2015;10:e0120587 pubmed publisher
  15. de Monès E, Schlaubitz S, Oliveira H, d Elbée J, Bareille R, Bourget C, et al. Comparative study of membranes induced by PMMA or silicone in rats, and influence of external radiotherapy. Acta Biomater. 2015;19:119-27 pubmed publisher
  16. Qi J, Wang W, Li F. Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer. Oncol Lett. 2015;9:1297-1302 pubmed
  17. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  18. Yuan L, Liu X. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism. Mol Med Rep. 2015;11:2449-58 pubmed publisher
  19. Pinheiro C, Garcia E, Morais Santos F, Scapulatempo Neto C, Mafra A, Steenbergen R, et al. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:751 pubmed publisher
  20. Aeimlapa R, Wongdee K, Charoenphandhu N, Suntornsaratoon P, Krishnamra N. Premature chondrocyte apoptosis and compensatory upregulation of chondroregulatory protein expression in the growth plate of Goto-Kakizaki diabetic rats. Biochem Biophys Res Commun. 2014;452:395-401 pubmed publisher
  21. Shen W, Chung S, Irhimeh M, Li S, Lee S, Gillies M. Systemic administration of erythropoietin inhibits retinopathy in RCS rats. PLoS ONE. 2014;9:e104759 pubmed publisher
  22. Yuan S, Jiang T, Sun L, Zheng R, Cao G, Ahat N, et al. Use of bone mesenchymal stem cells to treat rats with acute liver failure. Genet Mol Res. 2014;13:6962-80 pubmed publisher
  23. Bai X, Li X, Tian J, Zhou Z. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PLoS ONE. 2014;9:e96117 pubmed publisher
  24. Ferreira C, Siqueira D, Romitti M, Ceolin L, Brasil B, Meurer L, et al. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma. Int J Mol Sci. 2014;15:5323-36 pubmed publisher
  25. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  26. Xu W, Fan W, Yao K. Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model. J Biomed Res. 2012;26:372-80 pubmed publisher
  27. Wang W, Jiang H, Zhu H, Zhang H, Gong J, Zhang L, et al. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma. Oncol Lett. 2013;5:884-888 pubmed
  28. Tripathy D, Sanchez A, Yin X, Martinez J, Grammas P. Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen. Microvasc Res. 2012;84:278-85 pubmed publisher
  29. Dawson M, Opat S, Taouk Y, Donovan M, Zammit M, Monaghan K, et al. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma. Clin Cancer Res. 2009;15:714-22 pubmed publisher